SUPN R&D Expenses
Supernus Pharmaceuticals Inc · R&D Expenses
SUPN R&D Expenses
Latest reported$29.46Mperiod ending
SUPN Quarterly R&D Expenses ($7.46M → $29.46M)
Quarterly R&D Expenses
High-resolution chart · PNG
SUPN r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 29,463,000 | |
| 39,438,000 | |
| 27,827,000 | |
| 29,366,000 | |
| 22,115,000 | |
| 26,927,000 | |
| 28,647,000 | |
| 29,036,000 | |
| 26,183,000 | |
| 24,930,000 | |
| 23,347,000 | |
| 22,655,000 | |
| 24,379,000 | |
| 21,212,000 | |
| 17,774,000 | |
| 19,554,000 | |
| 16,385,000 | |
| 20,839,000 | |
| 21,078,000 | |
| 19,654,000 | |
| 15,455,000 | |
| 34,280,000 | |
| 17,938,000 | |
| 16,839,000 | |
| 22,247,000 | |
| 18,937,000 | |
| 19,792,000 | |
| 16,943,000 | |
| 16,970,000 | |
| 15,394,000 | |
| 29,841,000 | |
| 20,422,000 | |
| 20,038,000 | |
| 18,908,000 | |
| 16,173,000 | |
| 12,980,000 | |
| 10,823,000 | |
| 9,601,000 | |
| 13,252,000 | |
| 7,868,000 | |
| 11,109,000 | |
| 10,562,000 | |
| 9,446,000 | |
| 9,129,000 | |
| 6,878,000 | |
| 3,683,000 | |
| 5,772,000 | |
| 4,657,000 | |
| 4,677,000 | |
| 4,482,000 | |
| 5,402,000 | |
| 3,779,000 | |
| 3,542,000 | |
| 4,522,000 | |
| 5,150,000 | |
| 8,306,000 | |
| 4,703,000 | |
| 5,358,000 | |
| 7,500,000 | |
| 8,425,000 | |
| 7,251,000 | |
| 7,451,000 | |
| 9,069,298 | |
| 7,455,882 |